Saroja Pharma Industries India (NSE:SAROJA) ROCE %: 15.53% (As of Mar. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:SAROJA Saroja Pharma Industries India Ltd NSE:SAROJA
15 GF Score
Price ₹40.95
! 4 Warning Signs
View Full Analysis

What is Saroja Pharma Industries India ROCE %?

Saroja Pharma Industries India NSE:SAROJA +3.15% 15 ROCE % is 15.53% as of Mar. 2025. GuruFocus rates NSE:SAROJA with a GF Score™ of 15/100. The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Saroja Pharma Industries India's annualized ROCE % for the quarter that ended in Mar. 2025 was 15.53%.

Saroja Pharma Industries India  (NSE:SAROJA) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Saroja Pharma Industries India ROCE % Related Terms

Saroja Pharma Industries India ROCE % Historical Data

* Premium members only.

The historical data trend for Saroja Pharma Industries India's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Saroja Pharma Industries India ROCE % Chart

Saroja Pharma Industries India Annual Data
Trend Mar21 Mar22 Mar23 Mar24 Mar25
ROCE %
55.25 55.58 36.47 19.76 15.53

Saroja Pharma Industries India Semi-Annual Data
Mar21 Mar22 Mar23 Mar24 Mar25
ROCE % 55.25 55.58 36.47 19.76 15.53
NSE:SAROJA
15GF Score
Saroja Pharma Industries India Ltd NSE:SAROJA
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Saroja Pharma Industries India ROCE % Calculation

Saroja Pharma Industries India's annualized ROCE % for the fiscal year that ended in Mar. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2025 )  (A: Mar. 2024 )(A: Mar. 2025 )
=26.659/( ( (265.624 - 92.919) + (395.527 - 224.895) )/ 2 )
=26.659/( (172.705+170.632)/ 2 )
=26.659/171.6685
=15.53 %

Saroja Pharma Industries India's ROCE % of for the quarter that ended in Mar. 2025 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2025 )  (Q: Mar. 2024 )(Q: Mar. 2025 )
=26.659/( ( (265.624 - 92.919) + (395.527 - 224.895) )/ 2 )
=26.659/( ( 172.705 + 170.632 )/ 2 )
=26.659/171.6685
=15.53 %

(1) Note: The EBIT data used here is one times the annual (Mar. 2025) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 15.53% mean?
Saroja Pharma Industries India (NSE:SAROJA) has a ROCE % of 15.53% as of Mar. 2025.
Is Saroja Pharma Industries India's ROCE % too high?
Saroja Pharma Industries India's current ROCE % is 15.53%. The Drug Manufacturers industry median ROCE % is 6.81. Saroja Pharma Industries India's value of 15.53% is 128.2% above this industry median. Overall, Saroja Pharma Industries India has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Saroja Pharma Industries India's ROCE % compare to ZTS?
Saroja Pharma Industries India's ROCE % of 15.53% can be compared against companies in the Drug Manufacturers industry. The industry median ROCE % is 6.81. Saroja Pharma Industries India's value of 15.53% is 128.2% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Drug Manufacturers company?
The median ROCE % among Drug Manufacturers companies is 6.81, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Saroja Pharma Industries India's current ROCE % of 15.53% is 128.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Drug Manufacturers industry, the median ROCE % is 6.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Saroja Pharma Industries India's current ROCE % is 15.53%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Saroja Pharma Industries India stock overvalued right now?
Saroja Pharma Industries India (NSE:SAROJA) has a current ROCE % of 15.53%. The current ROCE % is 15.53% and 128.2% above the Drug Manufacturers industry median of 6.81. Saroja Pharma Industries India's overall GF Score™ is 15/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Saroja Pharma Industries India (NSE:SAROJA), the current ROCE % is 15.53% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Saroja Pharma Industries India Business Description

Address Jata Shankar Dosa Marg, Shop No. 209, 2ND Floor, Ecstacy, City of Joy, Mulund west, Mumbai, MH, IND, 400080
Saroja Pharma Industries India Ltd is a company engaged in the pharmaceutical and healthcare sector. The company trades in pharmaceutical active pharmaceutical ingredients, pharma intermediates, chemicals, and solvents used for pharmaceutical products, including human and veterinary medicines. The company has only one reportable business segment, which is pharma chemicals, such as thionyl chloride and pharmaceutical intermediates. Geographically, it operates in India, Asia Pacific, Europe, and other regions, with the majority of its revenue generated from India.
15GF Score

Get the complete analysis for NSE:SAROJA

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹40.95
Price